The regulatory tide is turning in Diginex’s favour, even as a critical corporate deadline slips by without official word. Europe’s supply-chain due diligence rules are tightening, and the company is positioning itself to catch that wave. Yet the market’s attention remains fixed on a different question: what happened to the $1.5 billion Resulticks deal?
The 12 June deadline for completing that merger came and went in silence. No confirmation, no extension, no statement from management. That silence, after a period that had already knocked more than a third off the stock, makes the recent 18% surge to $1.16 look more like a reflex than a conviction. Without an official closing announcement, the rally lacks a solid anchor.
Regulatory Tailwinds Drive Product Push
While the M&A clock ticks, Diginex is quietly building infrastructure for a world where compliance is no longer optional. The EU’s Omnibus I amendments to the Corporate Sustainability Due Diligence Directive (CSDDD) were published in February 2026 and entered into force in March. National implementation stretches to July 2028, with company-level compliance due by July 2029. That timeline gives breathing room, but the direction is unmistakable.
A patchwork of other regimes already applies: the UK Modern Slavery Act, Australia’s Modern Slavery Act, Canada’s Fighting Against Forced Labour Act, Germany’s supply-chain law, and the EU Forced Labour Regulation. Non-compliance risks product bans, market exclusion, fines and reputational damage. Against that backdrop, the market for human rights and supply-chain due diligence is estimated at $3.8 billion in 2025 and projected to reach $9.6 billion by 2034.
Diginex moved early in June 2026 with the announcement of its integrated Risk-to-Remedy solution. The product combines LUMEN for risk assessment with APPRISE for direct worker engagement, pulling evidence at the employee level, prioritising remedial actions and generating regulation-ready reports. It bridges the gap between corporate promises and verifiable proof.
Should investors sell immediately? Or is it worth buying Diginex?
Platform Consolidation Gains Pace
Beneath the product launches, a structural shift is under way. Diginex is merging its four operating units — Diginex, Plan A, Matter and The Remedy Project — into a single integrated platform. Sales, technology and operations are being unified. The aim is to offer combined data assets as institutional-grade compliance infrastructure for banks, asset managers and global corporations.
The ESG data arm Matter delivered a concrete proof point in May 2026. After upgrades to its AI extraction engine and data pipeline, the automation rate for carbon data extraction from corporate reports jumped from 25% to 80%. Matter serves institutions representing $20 trillion in assets under management — a signal that sustainability data is becoming a genuine input for risk and capital allocation, not just a reporting exercise.
Since listing on Nasdaq in January 2025, Diginex has completed acquisitions worth over $100 million: Matter DK ApS for $13 million, The Remedy Project for $7.6 million, and Plan A for $80 million. The integration of these pieces is being overseen by Carole Zibi, appointed Chief Marketing Officer to sharpen the brand. Zibi, formerly VP of Marketing at Plan A, brings experience from LinkedIn and Disney.
Financial Strains and the Merger Overhang
The strategic narrative is compelling, but the numbers tell a different story. Diginex’s trailing twelve-month revenue sits at roughly $3.6 million — a fraction of the $150 million that Resulticks would add, along with up to $50 million in operating profit. The contrast is extreme. In the first half of 2026, the net loss widened to $5.81 million, while cash reserves dropped to just $1.9 million.
A collapse of the Resulticks deal would leave Diginex in a precarious position. The recent stock rebound has done little to close the gap with the all-time high of nearly $319 reached in October 2025. The market is pricing in hope rather than certainty. The next regulatory filing or ad-hoc announcement will decide whether that hope is justified — or whether the platform story must stand on its own, without the safety net of a transformative acquisition.
Ad
Diginex Stock: Buy or Sell?! New Diginex Analysis from June 16 delivers the answer:
The latest Diginex figures speak for themselves: Urgent action needed for Diginex investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 16.
Diginex: Buy or sell? Read more here...
